BIO International Convention 2022: Advancing Collaboration in Life Sciences
BIO International Convention 2022 brought the global life sciences community to San Diego from June 13–16. Denise McNerney of Global Life Sciences Alliance attended the event. Nearly 10,000 professionals participated, representing more than 3,000 companies worldwide.
In addition, the conference included over 250 exhibitors and 50 sponsors. Together, attendees reflected on recent advances while focusing on stronger collaboration to accelerate clinical development.
A “Limitless” Environment for Connection
This year’s theme, Limitless, was clear throughout the event. The expansive venue encouraged frequent one-on-one meetings and spontaneous conversations. As a result, networking felt active and intentional.
Meanwhile, speaker sessions covered key industry topics. These included therapeutic innovation, digital health, patient advocacy, and next-generation biotherapeutics.
Key Topics and Industry Momentum
Throughout the event, discussions ranged from emerging technologies to the industry’s response to new FDA Guidance to increase ethnic and racial diversity in clinical trials.
Moreover, decision-makers and senior leaders showed a strong appetite for networking, actively seeking new partnerships and long-term collaborations beyond the conference floor.
Notable Networking Highlights
A standout networking event hosted by Farmacon Global generated significant interest in their upcoming 2nd Annual Virtual Conference, scheduled for August 25. The event will focus on Rare Diseases in Emerging Markets and is open to biopharma professionals, government agencies, healthcare providers, and patients. The goal is to explore the patient journey and encourage the development of treatments for rare diseases.
Social Engagement and Visibility
Photos from BIO 2022 were shared live across GLSA’s social media channels, driving engagement and increasing brand visibility for our clients and partners. If you’re not already involved in our promotional initiatives, we encourage you to follow and interact with GLSA on LinkedIn.
Upcoming Conferences to Watch
GLSA recommends the following events for the remainder of the year:
- Rare Diem (Rare Disease in Emerging Markets) – Virtual Meeting | August 25
- Society for Clinical Data Management (SCDM) – San Antonio, TX | September 11–14
- Society for Clinical Research Sites (SCRS) – Hollywood, FL | October 7–9
- Outsourcing in Clinical Trials New England, – Boston, MA | October 12–13
- CNS (Collaborating for Novel Solutions) Summit – Boca Raton, FL | November 17–20
Looking Ahead
If you would like to explore how Global Life Sciences Alliance can represent your organization at conferences and industry events, please reach out through our contact form or connect directly with your GLSA representative.
Connecting Innovative Resources
in Life Sciences to
Improve Patients’ Lives
~Hannah Lloyd / DMc
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.